However, further studies of PD-L1 immunostaining with larger cohorts of these rare DLBCL subtypes are needed to confirm this PD-L1 overexpression, as only 10% of PCNSL cases (n=2/20) were found to harbor PD-L1+ tumor cells [67]. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.